Pinsent Masons advises Synova Capital on DBG (UK) Limited disposal

17 Apr 2013 | 02:08 pm | 1 min. read

International law firm Pinsent Masons has advised Synova Capital on its disposal of DBG (UK) Limited to global alternative asset manager The Carlyle Group and Palamon Capital Partners.

Operating for over 20 years, dbg is a specialist healthcare support services provider of training, compliance support, engineering services, materials and equipment. Using a membership-based model, dbg works alongside over 8,000 dental, GP and veterinary practices throughout the UK, and is headquartered in Winsford, Cheshire.

Philip Shapiro, Managing Partner at Synova commented “We are very pleased with the completion of our successful investment in dbg. Since we acquired dbg in 2010, the membership base has more than doubled and profits have trebled.  Carlyle and Palamon have a clear vision and ability to continue this growth.”

Eric Kump, Managing Director at Carlyle said “dbg is a well-established business delivering clear benefits to its members, customers and suppliers. Carlyle and Palamon have a strong track record in this sector, having acquired Integrated Dental Holdings (“IDH”) in 2011.”

KPMG Corporate Finance acted as lead advisor, with Synova being advised by Andrew Hodgson and Tim Spooner. Andrew, Corporate Finance Partner at KPMG Bristol said that "dbg is an outstanding business and Synova has done a great job in reading how the market was developing and focusing dbg’s strategy accordingly.  dbg’s recent and forecast growth made it a very attractive business and I fully expect it to go from strength to strength in partnership with its new owners."

The Pinsent Masons team advising Synova on the deal was led by Corporate Partner Peter Wood and Senior Associate Michael Walby.  Commenting on the deal, Michael said: "We are very pleased to have worked with Synova and the dbg management team on this important transaction and wish dbg well in the next exciting stage of its development.”

Latest press releases

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons secures 11th place in Financial Times Diversity Leaders 2021 Report

Multinational law firm Pinsent Masons has been named as a top 20 Diversity Leader by the Financial Times, ranked 11th in its Diversity Leaders 2021 report.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ

Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts